Rifaximin treatment in hepatic encephalopathy.
Wang
Chia-Chi
CC
Kao
Jia-Horng
JH
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D010538:Peritonitis / Q000150:complications / Q000517:prevention & control; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin